Welcome to LookChem.com Sign In|Join Free
  • or
4-{4-(4-Fluorophenyl)-1-[1-(isoxazol-3-ylmethyl)piperidin-4-yl]-1H-imidazol-5-yl}pyrimidin-2-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1293395-67-1

Post Buying Request

1293395-67-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1293395-67-1 Usage

Biochem/physiol Actions

PF-5006739 is a potent inhibitor of casein kinases 1 delta (CK1δ) and 1 epsilon (CK1ε), key regulators of the suprachiasmatic nucleus (SCN) central clock and also linked to the development of drug addiction through PERIOD proteins (PER1–3) and dopamine- and cAMP-regulated neuronal phosphoprotein (DARPP-32) modulation. PF-5006739 has low nM in vitro potency for CK1δ/ε (IC50 values of 3.9 nM for CK1δ and 17.0 nM for CK1ε) and high kinome selectivity. PF-5006739 induced profound phase delays in circadian periodicity in both nocturnal and diurnal animal models and attenuated opioid drug-seeking behavior in a rodent operant reinstatement model.

Check Digit Verification of cas no

The CAS Registry Mumber 1293395-67-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,3,3,9 and 5 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1293395-67:
(9*1)+(8*2)+(7*9)+(6*3)+(5*3)+(4*9)+(3*5)+(2*6)+(1*7)=191
191 % 10 = 1
So 1293395-67-1 is a valid CAS Registry Number.

1293395-67-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (PZ0246)  PF-5006739  ≥98% (HPLC)

  • 1293395-67-1

  • PZ0246-5MG

  • 983.97CNY

  • Detail
  • Sigma

  • (PZ0246)  PF-5006739  ≥98% (HPLC)

  • 1293395-67-1

  • PZ0246-25MG

  • 3,970.98CNY

  • Detail

1293395-67-1Downstream Products

1293395-67-1Relevant academic research and scientific papers

Novel Compounds As Casein Kinase Inhibitors

-

Page/Page column 20-21, (2011/05/05)

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1293395-67-1